AIDS activists willing to risk their lives for chance at cure
September 22, 1997
Web posted at: 9:50 p.m. EDT (2150 GMT)
(CNN) -- There are times when science must take risks, says
Dr. Charles Farthing. And if mainstream science will not take
risks in the search for an AIDS cure, he says, then he will.
Even if it means his life.
Farthing, the medical director of the AIDS Healthcare
Foundation, is among several dozen people who have
volunteered to be injected with a live, weakened form of the
HIV virus.
The injections would be part of a research effort into
finding a protective vaccine against AIDS. It follows
experiments at Harvard Medical School using live vaccines on
monkeys.
"I was so frustrated that this very likely safe and effective
vaccine -- at least in my opinion -- has been stalled in
research and hasn't gone forward," Farthing said.
He said scientists had incorrectly believed that no one would
volunteer for the potentially lethal experiments. So he began
his own search for volunteers to be injected with the
experimental vaccine.
There is a risk," Farthing says. "But the reason for
doing the study is really to prove that it's very small."
Farthing and the International Association of Physicians in
AIDS Care issued a challenge on the group's Web site last
month asking for volunteers.
Among the more than 50 doctors, nurses and health policy
activists who answered Farthing's call is Joe Zuniga, a
former soldier in the U.S. Army.
Zuniga was a controversial figure in the 1993 furor over
homosexuals in the military, when he revealed that he was
gay. Despite having received a Soldier of the Year award from
the 6th Army, Zuniga was discharged.
Now deputy director of IAPAC, he says that risking his own
life in the fight against the deadly epidemic is a small
price for a potential cure.
"Considering that there are 8,000 new infections of HIV per
day, we think that bold steps should be taken while observing
good science," says Zuniga.
He is also convinced that the weakened, genetically altered
HIV virus that the group intends to use will not sicken the
experiment's subjects.
"We are not calling for a trial tomorrow, or even the next
day," he said. "We want there to be enough safety protocols
in place for this not to harm anybody."